{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:37Z","timestamp":1791520837040,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Since the diagnostic value of aldosterone to renin ratio (ARR) calculated by plasma renin concentration (PRC) or plasma renin activity (PRA) is still inconclusive, we conducted a meta-analysis by systematically reviewing relevant literature to explore the difference in the diagnostic efficacy of ARR calculated by PRC or PRA, so as to provide guidance for clinical diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, and Cochrane Library from the establishment of the database to March 2021. We included studies that report the true positive, false positive, true negative, and false negative values for the diagnosis of primary aldosteronism, and we excluded duplicate publications, research without full text, incomplete information, or inability to conduct data extraction, animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The pooled results showed that ARR (plasma aldosterone concentration [PAC]\/PRC) had a sensitivity of 0.82 (95% confidence interval [CI]: 0.78\u20130.86), a specificity of 0.94 (95% CI: 0.92\u20130.95), a positive-likelihood ratio (LR) of 12.77 (95% CI: 7.04\u201323.73), a negative LR of 0.11 (95% CI: 0.07\u20130.17), and symmetric area under the curve (SAUC) of 0.982, respectively. Furthermore, the diagnostic odds ratio (DOR) of ARR (PAC\/PRC) was 180.21. Additionally, the pooled results showed that ARR (PAC\/PRA) had a sensitivity of 0.91 (95% CI: 0.86\u20130.95), a specificity of 0.91 (95% CI: 0.90\u20130.93), a positive LR of 7.30 (95% CI: 2.99\u201317.99), a negative LR of 0.10 (95% CI: 0.04\u20130.26), and SAUC of 0.976, respectively. The DOR of ARR (PAC\/PRA) was 155.52. Additionally, we conducted a subgroup analysis for the different thresholds (&lt;35 or \u226535) of PAC\/PRC. The results showed that the DOR of the cut-off \u226535 groups was higher than the cut-off &lt;35 groups (DOR\u200a=\u200a340.15, 95% CI: 38.32\u20133019.66; DOR\u200a=\u200a116.40, 95% CI\u200a=\u200a23.28\u2013581.92).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The research results suggest that the determination of ARR (PAC\/PRC) and ARR (PAC\/PRA) was all effective screening tools for PA. The diagnostic accuracy and diagnostic value of ARR (PAC\/PRC) are higher than ARR (PAC\/PRA). In addition, within a certain range, the higher the threshold, the better the diagnostic value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001906","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T04:08:49Z","timestamp":1640837329000},"page":"639-647","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: a meta-analysis"],"prefix":"10.1097","volume":"135","author":[{"given":"Zhenjie","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[{"name":"Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China"},{"name":"Department of Clinical Laboratory, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,20]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"101365","DOI":"10.1016\/j.beem.2019.101365","article-title":"Prevalence, diagnosis and outcomes of treatment for primary aldosteronism","volume":"34","author":"Yang","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-21-0018","article-title":"Renin a marker for left ventricular hypertrophy in primary aldosteronism: a cohort study","volume":"185","author":"Kohler","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1354750X.2011.614015","article-title":"Two-site automated chemiluminescent assay for measurement of immunoreactive renin","volume":"16","author":"Gruson","year":"2011","journal-title":"Biomarkers"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.bjps.2019.03.021","article-title":"The scratch collapse test: a QUADAS-2 assessment of a systematic review","volume":"72","author":"Ryan","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/hr.2010.76","article-title":"Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism","volume":"33","author":"Balas","year":"2010","journal-title":"Hypertens Res"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-973061","article-title":"The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system","volume":"115","author":"Diederich","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the endocrine society practice guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41371-018-0112-8","article-title":"High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism","volume":"33","author":"Gan","year":"2019","journal-title":"J Hum Hypertens"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"2195796","DOI":"10.1155\/2019\/2195796","article-title":"Feasibility of screening primary aldosteronism by aldosterone-to-direct renin concentration ratio derived from chemiluminescent immunoassay measurement: diagnostic accuracy and cutoff value","volume":"2019","author":"Li","year":"2019","journal-title":"Int J Hypertens"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"3934212","DOI":"10.1155\/2020\/3934212","article-title":"High efficiency and problems of chemiluminescence assay-detected aldosterone-to-renin ratio in practical primary aldosteronism screening","volume":"2020","author":"Lin","year":"2020","journal-title":"Int J Hypertens"},{"key":"R16-20250603","first-page":"115","article-title":"Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism","volume":"4","author":"Corbin","year":"2011","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/js.2019-00145","article-title":"Diagnostic accuracy of the aldosterone-to-active renin ratio for detecting primary aldosteronism","volume":"3","author":"Pilz","year":"2019","journal-title":"J Endocr Soc"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin Chem"},{"key":"R20-20250603","article-title":"Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism","author":"Teruyama","year":"2021","journal-title":"J Hum Hypertens"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12020-007-9028-8","article-title":"The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses","volume":"32","author":"Tzanela","year":"2007","journal-title":"Endocrine"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/HJH.0000000000001718","article-title":"Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions","volume":"36","author":"Vorselaars","year":"2018","journal-title":"J Hypertens"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2008.02060.x","article-title":"The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism","volume":"39","author":"Willenberg","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"R24-20250603","article-title":"A real saline challenge: diagnosing primary aldosteronism in the setting of chronic kidney disease","volume":"9","author":"Mirfakhraee","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"R28-20250603","first-page":"524","article-title":"Risk on bias assessment: (6) a revised tool for the quality assessment on diagnostic accuracy studies (QUADAS-2) (in Chinese)","volume":"39","author":"Qu","year":"2018","journal-title":"Chin J Epidemiol"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"European study group for the validation of DiaSorin LDRA. A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin","volume":"28","author":"Morganti","year":"2010","journal-title":"J Hypertens"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:03:24Z","timestamp":1748963004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001906","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}